Thomas DL - Search Results

1

An Education and Field Experience Program to Increase Detection of Human Immunodeficiency Virus and Hepatitis C Virus.

Irvin R, McAdams-Mahmoud A, White JJ, Grant Z, Falade-Nwulia O, Sherman SG, Beyrer C, Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE. Irvin R, et al. Among authors: thomas dl. Prog Community Health Partnersh. 2018;12(1):101-109. doi: 10.1353/cpr.2018.0011. Prog Community Health Partnersh. 2018. PMID: 29606698 Free PMC article.

2

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Sulkowski MS, et al. Among authors: thomas dl. JAMA. 2000 Jan 5;283(1):74-80. doi: 10.1001/jama.283.1.74. JAMA. 2000. PMID: 10632283

3

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.

Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. Clin Infect Dis. 2000 Apr;30 Suppl 1:S77-84. doi: 10.1086/313842. Clin Infect Dis. 2000. PMID: 10770916 Review.

4

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Mehta SH, et al. Among authors: thomas dl. Ann Intern Med. 2000 Oct 17;133(8):592-9. doi: 10.7326/0003-4819-133-8-200010170-00009. Ann Intern Med. 2000. PMID: 11033586

5

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Mehta SH, et al. Among authors: thomas dl. Hepatology. 2001 Jun;33(6):1554. doi: 10.1053/jhep.2001.0103306le01. Hepatology. 2001. PMID: 11391549 No abstract available.

6

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Sulkowski MS, et al. Among authors: thomas dl. Hepatology. 2002 Jan;35(1):182-9. doi: 10.1053/jhep.2002.30319. Hepatology. 2002. PMID: 11786975

7

Peripheral blood count abnormalities among patients with hepatitis C in the United States.

Streiff MB, Mehta S, Thomas DL. Streiff MB, et al. Among authors: thomas dl. Hepatology. 2002 Apr;35(4):947-52. doi: 10.1053/jhep.2002.32486. Hepatology. 2002. PMID: 11915043

8

Peginterferon-alpha-2a (40kD) and ribavirin in patients with chronic hepatitis C: a phase II open-label study.

Sulkowski M, Reindollar R, Thomas DL, Brinkley-Laughton S, Hudson M, Yu J. Sulkowski M, et al. Among authors: thomas dl. BioDrugs. 2002;16(2):105-9. doi: 10.2165/00063030-200216020-00004. BioDrugs. 2002. PMID: 11985484 Clinical Trial.

9

Needlestick transmission of hepatitis C.

Sulkowski MS, Ray SC, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. JAMA. 2002 May 8;287(18):2406-13. doi: 10.1001/jama.287.18.2406. JAMA. 2002. PMID: 11988061

10

Protection against persistence of hepatitis C.

Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL. Mehta SH, et al. Among authors: thomas dl. Lancet. 2002 Apr 27;359(9316):1478-83. doi: 10.1016/S0140-6736(02)08435-0. Lancet. 2002. PMID: 11988247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

766 results

Search Page

Filters